Next Step in Evaluation: Radioactive Iodine Uptake (RAIU) and Scan
The next step is to obtain a radioactive iodine uptake (RAIU) test, with thyroid scan if nodularity is present, to determine the etiology of the thyrotoxicosis 1.
Clinical Context
Your patient has overt hyperthyroidism with:
- Suppressed TSH (<0.07)
- Elevated free T4 (1.7)
- Elevated free T3 (4.3)
This biochemical pattern confirms thyrotoxicosis, but the underlying cause must be identified before initiating treatment, as management differs significantly based on etiology 1.
When RAIU Can Be Skipped
The RAIU is not necessary only if the clinical presentation is unequivocally diagnostic of Graves' disease 1:
- Symmetrically enlarged thyroid gland on examination
- Recent onset of ophthalmopathy (Graves' orbitopathy)
- Moderate to severe hyperthyroidism
If these classic features are present, you can proceed directly to treatment without further diagnostic testing 1.
Why RAIU Is Critical When Diagnosis Is Uncertain
The RAIU distinguishes between two fundamentally different categories of thyrotoxicosis 1:
Elevated or Normal RAIU (thyroid is overproducing hormone):
- Graves' disease (diffuse uptake pattern)
- Toxic adenoma or toxic multinodular goiter (focal/patchy uptake)
- TSH-secreting pituitary adenoma (rare)
- Thyroid hormone resistance (rare)
Near-Absent RAIU (thyroid is releasing preformed hormone):
- Painless (silent) thyroiditis
- Subacute thyroiditis
- Amiodarone-induced thyroiditis
- Factitious thyroid hormone ingestion
- Struma ovarii
This distinction is crucial because conditions with low RAIU are typically self-limited and do not require definitive therapy (radioactive iodine, antithyroid drugs, or surgery), whereas conditions with elevated RAIU require active treatment 1.
Additional Considerations
If Thyroid Nodules Are Present
Add a thyroid scan to the RAIU to characterize the pattern of uptake and identify autonomous function 1.
Alternative First Step: Anti-TSH Receptor Antibodies
If you have high clinical suspicion for Graves' disease but lack the classic triad, anti-TSH receptor antibodies can be measured as an alternative first step 2. Modern assays have sensitivity and specificity approaching 100% for Graves' disease. If positive, RAIU may be unnecessary. If negative or unavailable quickly, proceed with RAIU 2.
Common Pitfalls to Avoid
- Do not start antithyroid drugs before establishing etiology - patients with thyroiditis will not benefit and may experience unnecessary side effects
- Recent iodine exposure (contrast studies, amiodarone) can suppress RAIU even in Graves' disease, potentially causing misdiagnosis 1
- Pregnancy is an absolute contraindication to RAIU - use clinical features and anti-TSH receptor antibodies instead 1
What Not to Do
Do not pursue evaluation for rare causes of elevated thyroid hormones with non-suppressed TSH (TSH-secreting pituitary adenoma, thyroid hormone resistance, assay interference) 1, 3. Your patient has suppressed TSH, which excludes these entities. These conditions present with elevated free T4/T3 but normal or elevated TSH 1, 3.